Modular Medical ships Pivot insulin kits
- Modular Medical (NASDAQ:MODD) has started shipping Pivot tubeless insulin patch pump starter kits to endocrinology practices for physician training.
- The system targets adults on multiple daily insulin injections, described as about 70% of insulin-dependent adults.
- The company said it plans a phased rollout across select high-volume clinics and metro markets through late 2026.
Modular Medical (NASDAQ:MODD) said it has begun shipping Pivot tubeless insulin patch pump starter kits to endocrinology practices to support physician training before wider patient access.
The rollout comes as the company moves from preparation into early clinical training distribution, rather than immediate broad commercial availability.
The kits will first be used in training settings, with patients expected to be offered access within days or weeks after clinicians complete onboarding.
The system is aimed at adults using multiple daily injections, a group the company estimates represents about 70% of insulin-dependent adults, and it described the segment as a multi-billion-dollar opportunity.
Modular Medical said its commercial strategy will begin with select high-volume endocrinology practices before expanding into additional metropolitan markets.
The Pivot system is a tubeless insulin patch pump designed to deliver insulin without traditional tubing, positioning it within the broader shift toward wearable diabetes management devices.
